Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity (Details Narrative)

v3.23.1
Shareholders Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Apr. 27, 2023
Apr. 26, 2023
Mar. 31, 2023
Feb. 17, 2023
Jan. 23, 2023
Apr. 30, 2021
Mar. 31, 2023
Mar. 31, 2022
Apr. 25, 2023
Dec. 31, 2022
Jun. 03, 2022
Aug. 01, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, par or stated value per share     $ 0.0001       $ 0.0001     $ 0.0001    
Share based compensation             $ 192,061 $ 470,685        
Issuance of common stock             25,308        
Stockissuedduringperiod,value,newissues                      
Share based payment award options and warrants outstanding intrinsic value     $ 0       0     $ 0    
Stock compensation expense             $ 192,000          
Common stock, shares authorized     50,000,000       50,000,000     50,000,000    
Preferred stock, shares authorized     5,000,000       5,000,000     5,000,000    
Subsequent Event [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stockholders' equity, reverse stock split 1-for-8 reverse stock split one-for-eight (1-for-8) reverse split                    
Executives [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stockissuedduringperiod,shares,newissues             54,824          
Stockissuedduringperiod,value,newissues             $ 50,000          
Restricted Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Unrecognized stock compensation expense related to restricted stock     $ 124,000       $ 124,000          
Weighted-average period             7 months 6 days          
Stock compensation expense             $ 139,000          
Share-Based Payment Arrangement, Option [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Weighted-average period             1 year 9 months 18 days          
Unrecognized stock compensation expense related to stock options     $ 135,000       $ 135,000          
Options Granted to Executive [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock compensation expense             50,000          
Options Granted to Consultants [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock compensation expense             $ 3,000          
Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stockissuedduringperiod,shares,newissues             8,393          
Stockissuedduringperiod,value,newissues             $ 1          
Common Stock [Member] | Subsequent Event [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, shares authorized 50,000,000               500,000,000      
Preferred stock, shares authorized 5,000,000               50,000,000      
Director [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued during period shares restricted stock award gross             10,417          
Director [Member] | Common Stock [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Share based compensation             $ 40,000          
Underwriter [Member] | IPO [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Warrant to purchase common stock     44,922       44,922          
Warrants exercisable date             Mar. 14, 2022          
Warrants exercisable date             Sep. 14, 2026          
Exercise price per share     $ 40.00       $ 40.00          
Lender [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Warrants exercisable date           Sep. 14, 2024            
Exercise price per share           $ 40.00            
Number of warrants issued           13,286            
Sales Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Proceeds from issuance initial public offering       $ 2,096,000                
Fixed commission rate percentage       3.00%                
Share based compensation       $ 50,000                
Stockissuedduringperiod,shares,newissues     8,393                  
Issuance of common stock     $ 26,601                  
Sales Agreement [Member] | First Three Quarters [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Other expenses       7,500                
Sales Agreement [Member] | Fourth Quarter [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Other expenses       $ 10,000                
Consulting Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued during period shares restricted stock award gross         200,000              
Description of vesting rights         Within each of the aforementioned Option Agreements, 90% of the vesting is related to performance conditions and 10% time-based vesting.              
First Option Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued during period shares restricted stock award gross         62,500              
Exercise price         $ 4.80              
Expiration date         5 years              
Second Option Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued during period shares restricted stock award gross         50,000              
Exercise price         $ 8.00              
Expiration date         5 years              
Third Option Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued during period shares restricted stock award gross         50,000              
Exercise price         $ 10.00              
Expiration date         5 years              
Fourth Option Agreement [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued during period shares restricted stock award gross         37,500              
Exercise price         $ 14.00              
Expiration date         5 years              
Consultant [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued for services               1,250        
Sellers [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Stock issued for services               5,040        
Think Equity LLC [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common stock, par or stated value per share       $ 0.0001                
2020 Equity Incentive Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common Stock, Capital Shares Reserved for Future Issuance                       239,155
2022 Equity Incentive Plan [Member]                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Common Stock, Capital Shares Reserved for Future Issuance                     325,000